| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/AJH.2011.62 |
| P698 | PubMed publication ID | 21472019 |
| P50 | author | Kedra Wallace | Q56256861 |
| Florian Herse | Q47804678 | ||
| P2093 | author name string | Babbette LaMarca | |
| Ralf Dechend | |||
| Katrin Wenzel | |||
| James N Martin | |||
| Gerd Wallukat | |||
| Abram Weimer | |||
| Marc R Parrish | |||
| Kathy Cockrell | |||
| Kiran B Tam Tam | |||
| Lillian F Ray | |||
| Marrietta Arany | |||
| P2860 | cites work | Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. | Q54661322 |
| Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Pathophysiology of pregnancy-induced hypertension | Q74039094 | ||
| Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats | Q77945719 | ||
| Role of Reactive Oxygen Species During Hypertension in Response to Chronic Antiangiogenic Factor (sFlt-1) Excess in Pregnant Rats | Q35086662 | ||
| Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia | Q35681821 | ||
| Oxidative stress and preeclampsia: rationale for antioxidant clinical trials | Q35869763 | ||
| Activating auto-antibodies against the AT1 receptor in preeclampsia | Q36010629 | ||
| Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling | Q36050771 | ||
| Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia | Q36380482 | ||
| The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
| Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease | Q36889241 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats | Q37449704 | ||
| Placental cytokines and the pathogenesis of preeclampsia | Q41452017 | ||
| Inducible nitric oxide synthase inhibition attenuates renal hemodynamics during pregnancy | Q43908262 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Role of reactive oxygen species in endothelin-induced hypertension | Q44521159 | ||
| L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure | Q44760481 | ||
| Role of oxidative stress in the sex differences in blood pressure in spontaneously hypertensive rats | Q46388265 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. | Q51359651 | ||
| Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
| P433 | issue | 7 | |
| P921 | main subject | reactive oxygen species | Q424361 |
| hypertension | Q95566669 | ||
| P304 | page(s) | 835-840 | |
| P577 | publication date | 2011-04-07 | |
| P1433 | published in | Journal of Clinical Hypertension | Q15762840 |
| P1476 | title | Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension | |
| P478 | volume | 24 |
| Q37624176 | 2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor. |
| Q53700889 | AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats. |
| Q37507162 | Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy |
| Q34541831 | Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy |
| Q36355165 | Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia |
| Q36339336 | An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia |
| Q34040357 | Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia |
| Q36339273 | Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats |
| Q34508485 | CD4(+) T Cells Play a Critical Role in Mediating Hypertension in Response to Placental Ischemia |
| Q35153877 | CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia. |
| Q93109012 | Disturbed Cardiorespiratory Adaptation in Preeclampsia: Return to Normal Stress Regulation Shortly after Delivery? |
| Q37353537 | Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy |
| Q34072217 | Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats |
| Q36380039 | GPCRs as potential therapeutic targets in preeclampsia. |
| Q36244980 | Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation |
| Q36997267 | IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia |
| Q36178540 | IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy |
| Q37139722 | Identifying immune mechanisms mediating the hypertension during preeclampsia |
| Q36107337 | Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion |
| Q34140082 | Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia |
| Q38017497 | Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome |
| Q26865332 | Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology |
| Q37451544 | Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia |
| Q37541001 | Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension. |
| Q38889590 | Preeclampsia and the brain: neural control of cardiovascular changes during pregnancy and neurological outcomes of preeclampsia |
| Q26800272 | Preeclampsia: long-term consequences for vascular health |
| Q28395340 | Pregnant rats treated with a high-fat/prooxidant Western diet with ANG II and TNF-α are resistant to elevations in blood pressure and renal oxidative stress |
| Q33983395 | Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy |
| Q38691672 | Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy |
| Q35707881 | Receptor-activating autoantibodies and disease: preeclampsia and beyond |
| Q45848306 | Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy |
| Q92071252 | Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy |
| Q37385038 | TH17- and IL-17- mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia |
| Q27003301 | The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? |
| Q57150158 | The role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia |
Search more.